246 related articles for article (PubMed ID: 10981044)
1. Endothelin in heart failure.
Sütsch G; Barton M
Curr Hypertens Rep; 1999; 1(1):62-8. PubMed ID: 10981044
[TBL] [Abstract][Full Text] [Related]
2. Endothelin in cardiovascular control: the role of endothelin antagonists.
Wenzel RR; Czyborra P; Lüscher T; Philipp T
Curr Hypertens Rep; 1999; 1(1):79-87. PubMed ID: 10981046
[TBL] [Abstract][Full Text] [Related]
3. Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
Spieker LE; Noll G; Ruschitzka FT; Lüscher TF
J Am Coll Cardiol; 2001 May; 37(6):1493-505. PubMed ID: 11345356
[TBL] [Abstract][Full Text] [Related]
4. Vascular effects of endothelin-1 in essential hypertension: relationship with cyclooxygenase-derived endothelium-dependent contracting factors and nitric oxide.
Taddei S; Virdis A; Ghiadoni L; Salvetti A
J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S37-40. PubMed ID: 10976779
[TBL] [Abstract][Full Text] [Related]
5. Endothelium-dependent responses in congestive heart failure.
Vanhoutte PM
J Mol Cell Cardiol; 1996 Nov; 28(11):2233-40. PubMed ID: 8938576
[TBL] [Abstract][Full Text] [Related]
6. Endothelin and endothelin antagonists in hypertension.
Schiffrin EL
J Hypertens; 1998 Dec; 16(12 Pt 2):1891-5. PubMed ID: 9886874
[TBL] [Abstract][Full Text] [Related]
7. [Sympathetic nervous system and endothelial function in heart failure].
Binggeli C; Wenzel RR; Noll G
Praxis (Bern 1994); 1996 Feb; 85(8):234-44. PubMed ID: 8701190
[TBL] [Abstract][Full Text] [Related]
8. Vascular protection: current possibilities and future perspectives.
Lüscher TF
Int J Clin Pract Suppl; 2001 Jan; (117):3-6. PubMed ID: 11715356
[TBL] [Abstract][Full Text] [Related]
9. Myocardial effects of endothelin-1.
Brás-Silva C; Leite-Moreira AF
Rev Port Cardiol; 2008; 27(7-8):925-51. PubMed ID: 18959090
[TBL] [Abstract][Full Text] [Related]
10. The potential role of endothelin as a vasoconstrictor substance in congestive heart failure.
Cody RJ
Eur Heart J; 1992 Nov; 13(11):1573-8. PubMed ID: 1464346
[TBL] [Abstract][Full Text] [Related]
11. Effect of endothelin-1 on endothelium-derived vascular responsiveness in man.
Krum H; Cranswick N; Pellizzer AM
Clin Sci (Lond); 1998 Aug; 95(2):151-6. PubMed ID: 9680496
[TBL] [Abstract][Full Text] [Related]
12. Endothelin as a regulator of cardiovascular function in health and disease.
Haynes WG; Webb DJ
J Hypertens; 1998 Aug; 16(8):1081-98. PubMed ID: 9794709
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats.
Sakai S; Miyauchi T; Sakurai T; Yamaguchi I; Kobayashi M; Goto K; Sugishita Y
J Am Coll Cardiol; 1996 Nov; 28(6):1580-8. PubMed ID: 8917275
[TBL] [Abstract][Full Text] [Related]
14. Endothelin and endothelin receptor antagonism in heart failure.
Sütsch G; Kiowski W
J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S69-73. PubMed ID: 10976786
[TBL] [Abstract][Full Text] [Related]
15. The endothelium in coronary artery disease.
Ruschitzka FT; Noll G; Lüscher TF
Cardiology; 1997; 88 Suppl 3():3-19. PubMed ID: 9397288
[TBL] [Abstract][Full Text] [Related]
16. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
Ohnishi M; Wada A; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Wang X; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095
[TBL] [Abstract][Full Text] [Related]
17. Evidence for vasoconstriction mediated by the endothelin-B receptor in domestic swine.
Burke SE; Nelson RA; Lubbers NL; Ford TT; Fu KI; Padley RJ; Wegner CD; Cox BF
J Cardiovasc Pharmacol; 2000 Jun; 35(6):838-44. PubMed ID: 10836715
[TBL] [Abstract][Full Text] [Related]
18. The role of endothelin in the pathogenesis of heart failure.
Teerlink JR
Curr Cardiol Rep; 2002 May; 4(3):206-12. PubMed ID: 11960589
[TBL] [Abstract][Full Text] [Related]
19. Effects of hypertension, diabetes mellitus, and hypercholesterolemia on endothelin type B receptor-mediated nitric oxide release from rat kidney.
Kakoki M; Hirata Y; Hayakawa H; Tojo A; Nagata D; Suzuki E; Kimura K; Goto A; Kikuchi K; Nagano T; Omata M
Circulation; 1999 Mar; 99(9):1242-8. PubMed ID: 10069794
[TBL] [Abstract][Full Text] [Related]
20. Influence of endothelial mediators on the vascular smooth muscle and circulating platelets and blood cells.
Warner TD
Int Angiol; 1996 Jun; 15(2):93-9. PubMed ID: 8803631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
